Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "research-partnerships"

6 News Found

NIPER Hajipur, Boehringer Ingelheim India ink MoU to boost translational pharma research
Policy | April 25, 2026

NIPER Hajipur, Boehringer Ingelheim India ink MoU to boost translational pharma research

As part of the partnership, Boehringer Ingelheim will provide access to its opnMe® platform, enabling broader scientific exchange and driving innovation-led research.


ACC Asia 2026 to spotlight next-gen cardiovascular care across Asia-Pacific
Healthcare | April 17, 2026

ACC Asia 2026 to spotlight next-gen cardiovascular care across Asia-Pacific

American College of Cardiology and Korean Society of Cardiology convene global experts to address rising cardiometabolic burden


Almirall opens Shanghai hub to power dermatology innovation and China partnerships
Biopharma | March 14, 2026

Almirall opens Shanghai hub to power dermatology innovation and China partnerships

The move comes as China rapidly expands its capabilities in the pharmaceutical sector, particularly in licensing and drug development


BioMed X launches groundbreaking AI-driven diabetes research in Barbados
News | January 30, 2026

BioMed X launches groundbreaking AI-driven diabetes research in Barbados

With its unique combination of AI, population-specific research, and international collaboration, BioMed X’s Barbados project represents a bold new frontier in precision medicine for diabetes and kidney disease


Godavari Biorefineries ED Sangeeta Srivastava named BRSI Honorary Fellow
People | December 16, 2025

Godavari Biorefineries ED Sangeeta Srivastava named BRSI Honorary Fellow

Dr Srivastava was selected by an expert jury in recognition of her sustained contributions to renewable chemicals, industrial biotechnology and bioprocess innovation


Strand Therapeutics appoints Dr. Prashant Nambiar as Senior VP
People | February 09, 2022

Strand Therapeutics appoints Dr. Prashant Nambiar as Senior VP

Senior R&D leader from Pfizer and bluebird bio to support Strand’s platform of programmable mRNA-based therapeutics